BAXTER INTERNATIONAL INC. Depreciation
BAXTER INTERNATIONAL INC. (BAX) reported Depreciation of $94.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-07-30
- BAXTER INTERNATIONAL INC. depreciation for the quarter ending 2026-06-30 was $94.00M, a 11.32% decline year-over-year.
- BAXTER INTERNATIONAL INC. depreciation for the quarter ending 2026-03-31 was $91.00M, a 1.09% decline year-over-year.
- BAXTER INTERNATIONAL INC. depreciation for the quarter ending 2025-12-31 was $95.00M, a 4.40% increase year-over-year.
- BAXTER INTERNATIONAL INC. depreciation for the quarter ending 2025-09-30 was $90.00M, a 5.26% decline year-over-year.
- BAXTER INTERNATIONAL INC. depreciation for fiscal 2025 was $383.00M, a 2.96% increase from fiscal 2024.
- BAXTER INTERNATIONAL INC. depreciation for fiscal 2024 was $372.00M, a 5.58% decline from fiscal 2023.
- BAXTER INTERNATIONAL INC. depreciation for fiscal 2023 was $394.00M, a 0.25% increase from fiscal 2022.
- BAXTER INTERNATIONAL INC. depreciation for fiscal 2022 was $393.00M, a 30.93% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $94.00M 10-Q · filed 2026-07-30 | $185.00M 10-Q · filed 2026-07-30 | $280.00M derived: sum of 3 quarters · filed 2026-07-30 | $370.00M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | $91.00M 10-Q · filed 2026-04-30 | $186.00M derived: sum of 2 quarters · filed 2026-04-30 | $276.00M derived: sum of 3 quarters · filed 2026-04-30 | $382.00M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | $95.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $185.00M derived: sum of 2 quarters · filed 2026-02-12 | $291.00M derived: sum of 3 quarters · filed 2026-07-30 | $383.00M 10-K · filed 2026-02-12 | |
| 2025-09-30 | $90.00M 10-Q · filed 2025-11-04 | $196.00M derived: sum of 2 quarters · filed 2026-07-30 | $288.00M 10-Q · filed 2025-11-04 | $379.00M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | $106.00M 10-Q · filed 2026-07-30 | $198.00M 10-Q · filed 2026-07-30 | $289.00M derived: sum of 3 quarters · filed 2026-07-30 | $384.00M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | $92.00M 10-Q · filed 2026-04-30 | $183.00M derived: sum of 2 quarters · filed 2026-04-30 | $278.00M derived: sum of 3 quarters · filed 2026-04-30 | $351.00M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | $91.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $186.00M derived: sum of 2 quarters · filed 2026-02-12 | $259.00M derived: sum of 3 quarters · filed 2026-02-12 | $372.00M 10-K · filed 2026-02-12 | |
| 2024-09-30 | $95.00M 10-Q · filed 2025-11-04 | $168.00M derived: sum of 2 quarters · filed 2025-11-04 | $281.00M 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $73.00M 10-Q · filed 2025-08-05 | $186.00M 10-Q · filed 2025-08-05 | |||
| 2024-03-31 | $113.00M 10-Q · filed 2025-05-06 | ||||
| 2023-12-31 | $394.00M 10-K · filed 2026-02-12 | $611.00M 10-K · filed 2024-02-08 | |||
| 2022-12-31 | $393.00M 10-K · filed 2025-02-21 | $650.00M 10-K · filed 2023-02-09 | |||
| 2021-12-31 | $569.00M 10-K · filed 2024-02-08 | $592.00M 10-K · filed 2022-02-23 | |||
| 2020-12-31 | $601.00M 10-K · filed 2023-02-09 | ||||
| 2019-12-31 | $606.00M 10-K · filed 2022-02-23 | ||||
| 2018-12-31 | $602.00M 8-K · filed 2021-04-29 | $613.00M 10-K · filed 2019-02-21 | |||
| 2017-12-31 | $596.00M 10-K · filed 2020-03-17 | $607.00M 10-K · filed 2018-02-23 | |||
| 2016-12-31 | $632.00M 10-K · filed 2019-02-21 | ||||
| 2015-12-31 | $597.00M 8-K · filed 2018-08-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |